Skip to main content
Log in

Is Perineural Invasion More Accurate Than Other Factors to Predict Early Recurrence after Pancreatoduodenectomy for Pancreatic Head Adenocarcinoma?

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Some patients operated by pancreaticoduodenectomy for resectable pancreatic head adenocarcinoma will present with a recurrence during the first year (early recurrence).

Objective

The aim of this study was to determine prognostic factors associated with early recurrence in a large retrospective study.

Methods

From January 1995 to November 2010, all patients operated by pancreaticoduodenectomy for pancreatic head adenocarcinoma in our institution were retrospectively included. Univariate and multivariate analyses were performed to determine factors associated with early recurrence.

Results

A total of 166 patients were included; 57 patients (34 %) developed early recurrence. In univariate analysis, factors associated with early recurrence were perineural invasion (p = 0.0002), preoperative bilirubin (p = 0.01), lymph node ratio (LNR) ≥0.2 (p = 0.009), and T stage (p = 0.02). In multivariate analysis, perineural invasion (odds ratio [OR] 3.31; 95 % confidence interval [CI] 1.42–7.72; p = 0.005), LNR ≥0.2 (OR 2.55; 95 % CI 1.17–5.52; p = 0.02), and preoperative bilirubin (OR 1.04; 95 % CI 1.01–1.07; p = 0.03) were independent factors associated with early recurrence. Perineural invasion was also associated with poor overall survival (p = 0.001) and poor disease-free survival (p = 0.07).

Conclusion

In our study, perineural invasion (OR 3.31) is more accurate than T stage and lymph node status (OR 2.55) to predict early recurrence after pancreatoduodenectomy for pancreatic head adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Trede M, Schawall G, Saeger HD (1990) Survival after pancreaticoduodenectomy. 118 Consecutive resections without an operative mortality. Ann Surg 211:447–458

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Yeo CJ, Cameron JL, Sohn TA et al (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications and outcomes. Ann Surg 226:248–257

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Nitecki SS, Sarr MG, Colby TV et al (1995) Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59–66

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Moreaux J, Catala M, Marzano L (1984) Results of the surgical treatment of pancreatic cancer. Study of a series of 96 surgically treated patients. Gastroenterol Clin Biol 8:11–16

    CAS  PubMed  Google Scholar 

  5. Magistrelli P, Antinori A, Crucitti A et al (2000) Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol 74:36–40

    Article  CAS  PubMed  Google Scholar 

  6. Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277

    Article  CAS  PubMed  Google Scholar 

  7. Neoptolemos JP, Moore MJ, Cox TF et al (2012) Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308:147–156

    Article  CAS  PubMed  Google Scholar 

  8. Kim EJ, Ben-Jospef E, Herman JM et al (2013) A multi-institutional phase 2 study of neo adjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer 119:2692–2700

    Article  CAS  PubMed  Google Scholar 

  9. Zhang Y, Adam EF, Kyriakides C et al (2012) Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemotherapy. J Cancer Res Clin Oncol 138:1063–1071

    Article  CAS  PubMed  Google Scholar 

  10. Slidell MB, Chang DC, Cameron JL et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15:165–174

    Article  PubMed  Google Scholar 

  11. Verbeke CS, Menon KV (2009) Redefining resection margin status in pancreatic cancer. HPB (Oxf) 11:282–289

    Article  Google Scholar 

  12. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and result of Survey. Ann Surg 240:205–213

    Article  PubMed Central  PubMed  Google Scholar 

  13. Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13

    Article  PubMed  Google Scholar 

  14. Wente MN, Bassi C, Dervenis C et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142:761–768

    Article  PubMed  Google Scholar 

  15. Hartwig W, Hackert T, Hinz U et al (2011) Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 254:311–319

    Article  PubMed  Google Scholar 

  16. Helm J, Centeno BA, Coppola D et al (2009) Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Cancer 115:4080–4089

    Article  PubMed  Google Scholar 

  17. Jentzer A (1930) Neurotropisme des cellules cancéreuses: clinique et thérapeutique des cancers neurotropes. Schweiz Med Wochenschr 60:1050–1052

    Google Scholar 

  18. Obyama K (1984) Clinicopathologic study on resected cases of carcinoma of the pancreas: prognosis and lymphatic metastasis. Jpn J Surg 85:820–834

    Google Scholar 

  19. Chen JW, Bhandari M, Astill DS et al (2010) Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion. HPB (Oxf) 12:101–108

    Article  Google Scholar 

  20. Shimada K, Nara S, Esaki M et al (2011) Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas. Pancreas 40:464–468

    Article  PubMed  Google Scholar 

  21. Neoptolemos JP, Stocken DD, Bassi C et al (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304:1073–1081

    Article  CAS  PubMed  Google Scholar 

  22. Conroy T, Desseigne F, Ychou M et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–1825

    Article  CAS  PubMed  Google Scholar 

  23. Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337–1344

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmet Ayav.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fouquet, T., Germain, A., Brunaud, L. et al. Is Perineural Invasion More Accurate Than Other Factors to Predict Early Recurrence after Pancreatoduodenectomy for Pancreatic Head Adenocarcinoma?. World J Surg 38, 2132–2137 (2014). https://doi.org/10.1007/s00268-014-2465-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-014-2465-7

Keywords

Navigation